ATAGI advice (updated): alternatives during supply shortage of adult hepatitis B vaccines
The Australian Technical Advisory Group on Immunisation (ATAGI) has provided advice regarding alternatives during supply shortage of the adult formulations of hepatitis B vaccines.
There is currently a shortage of the adult formulation of Engerix-B® available to Australia. The shortage has impacted on private market supply.
Supply for the National Immunisation Program (NIP) has not been affected at this time, so vaccination using the adult formulation of hepatitis B vaccines should continue as scheduled for eligible individuals.
Please refer to the document below which provides clinical advice to assist in using alternate hepatitis B vaccines during supply shortages.